The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

It comes as Health Secretary Robert F. Kennedy Jr. and his appointees continue to scrutinize the use of vaccines for a number ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...

(Reuters) -Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...